Shilpa Medicare Quarterly Results for Trading Insights
SHILPAMED • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹44 Cr
QSept 2025
Shilpa Medicare Quarterly Results Key Highlights
- Revenue of ₹372 Cr in Sept 2025 (+9.1% vs Mar 2025, +6.6% vs Sept 2024)
- Net Profit of ₹44 Cr in Sept 2025 (+193.3% vs Mar 2025, +144.4% vs Sept 2024)
- EBITDA of ₹110 Cr in Sept 2025 (+86.4% vs Mar 2025)
- Operating Margin of 29.0% in Sept 2025 (+14.0pp vs Mar 2025)
- Earnings Per Share of ₹5.50 in Sept 2025 (+271.6% vs Mar 2025)
Shilpa Medicare Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 372 | 341 | 328 | 349 | 300 | 9.1% | 6.6% |
| Net Profit (₹ Cr) | 44 | 15 | 47 | 18 | 25 | - | - |
| EBITDA (₹ Cr) | 110 | 59 | 97 | 91 | 79 | - | - |
| EPS (₹) | 5.50 | 1.48 | 4.79 | 1.83 | 2.82 | - | - |
| Operating Margin (%) | 29.0% | 15.0% | 28.0% | 25.0% | 24.0% | - | - |
Shilpa Medicare Share Price Trend Around Quarterly Results
Visualize Shilpa Medicare's 1-year price movement across quarterly results — ideal for logging trades in Shilpa Medicare share price
chart using Tickjournal. All values in ₹.
Related Pages for Shilpa Medicare
Additional stock information and data for SHILPAMED
Revenue Trend (₹ Cr)
Sept 2024
349
Jun 2025
328
Mar 2025
341
Sept 2025
372
Net Profit Trend (₹ Cr)
Sept 2024
18
Jun 2025
47
Mar 2025
15
Sept 2025
44
Operating Margin Trend (%)
Sept 2024
25.0%
Jun 2025
28.0%
Mar 2025
15.0%
Sept 2025
29.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Shilpa Medicare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores